A rational basis for mucosal vaccination against HIV infection

Immunological Reviews

Volumn 170, Issue , 1999, Pages 183-196

  Lehner, Thomas ^a   Bergmier, Lesley ^a   Wang, Yufei ^a   Tao, Louisa ^a   Mitchell, Elaine ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN P27; RANTES;

ANTIBODY RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION;

AIDS VACCINES; ANIMALS; CHEMOKINES, CC; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; LYMPH NODES; MALE; MUCOUS MEMBRANE; RECTUM; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VAGINA;

EID: 0032873577     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01338.x     Document Type: Review

References (80)

1. 1. WHO. Report on the global HIV/AIDS epidemic. Geneva: WHO; 1998.
2. 2. Hussain LA, Lehner T. Comparative investigation of Langerhans cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995;85:475-484.
3. 3. Winkelstein W, Wiley JA, Padian N, Levy J. Potential for transmission of AIDS-associated retrovirus from bisexual men in San Francisco to their female sexual contacts. JAMA 1986;255:901.
4. 4. Curran JW, Morgan WM, Hardy AM, Jaffe HW, Darrow WW, Dowdle WR. The epidemiology of AIDS: current status and future prospects. Science 1985;229:1352-1357.
5. 5. Mayer KH, Ayotte D, Groopman JE, Stoddard AM, Sarrgadharan M, Gallo R. Association of human T lymphotropic virus type III antibodies with sexual and other behaviour in a cohort of homosexual men from Boston with and without generalised lymphadenopathy. Am J Med 1986;80:357-363.
6. 6. Simonsen JN, Cameron DW, Gakinya MN. Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a center in Africa. N Engl J Med 1988;319:274-278.
7. 7. Cameron DW, Simonsen JN, D'Costa LJ. Female to male transmission of human immunodeficiency virus type 1 : risk factors for seroconversion in men. Lancet 1989;2:403-407.
8. 8. Bourinbaiar AS, Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:56-63.
9. 9. Yahi N, Baghdiguian S, Moreau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type I on human colon epithelial HT29 cells. J Virol 1992;66:4848-4854.
10. 10. Furuta Y, et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type I is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 1994;91:12559-12563.
11. 11. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell barrier. Nat Med 1997;3:42-47.
12. 12. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-767.
13. 13. Klatzmann D, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-768.
14. 14. Granelli-Piperno A, Pope M, Inaba K, Steinman RM. Co-expression of NF-κ B/Rel and Sp1 transcription factors in human immunodeficiency virus 1 -induced dendritic cell-T-cell syncytia. Proc Natl Acad Sci USA 1995;92:10944-10948.
15. 15. Macatonia SE, Patterson ES, Knight SC. Suppression of immune responses by dendritic cells infected with HIV. Immunology 1989;67:285.
16. 16. Kreiss JK, Hopkins SG. The association between circumcision status and human immunodeficiency virus infection among homosexual men. J Infect Dis 1992;168:1404-1408.
17. 17. Dossey DE. HIV and orogenital transmission. Lancet 1988;ii:1023.
18. 18. Detels R, Visschers B. HIV and orogenital transmission. Lancet 1988;ii:1023.
19. 19. Owen RL, Nemanic P. Antigen processing structures of the mammalian intestinal tract: an SEM study of lymphoepithelial organs. Scan Electron Microsc 1978;2:367-378.
20. 20. O'Leary AD, Sweeny EC. Lymphoglandular complexes of the colon: structure and distribution. Histopathology 1986;10:267-283.
21. 21. Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR. Transepithelial transport of HIV-1 by intestinal M ceils: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:760-765.
22. 22. Czerkinsky C, Russell MW, Lycke N, Lindblad M, Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 1989;57:1072-1077.
23. 23. McDermott MR, Bienenstock J. Evidence for a common mucosal system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J Immunol 1979;122:1892-1898.
24. 24. Wira CR, Sandoe CP, Specific IgA and IgG antibodies in tlie secretions of the female reproductive tract effects of immunization and estradiol on expression of this response in vivo. J Immunol 1987;138,4159-4164.
25. 25. Wira CR, Sandoe CP. Effect of uterine immunization and oestradiol on specific IgA and IgG antibodies in uterine vaginal and salivary secretions. Immunology 1989;68:24-30.
26. 26. Lehner T, Panagiotidi C, Bergmeier LA, Tao L, Brookes K, Adams S. A comparison of the immune responses following oral, vaginal or rectal route of immunization with SIV antigen in non-human primates. Vaccine Res 1992;1:319-330.
27. 27. Marx PA, et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323-1327.
28. 28. Lehner T, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 1996;2:767-775.
29. 29. Lehner T, et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992;258:1365-1369.
30. 30. Lehner T, et al. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol 1994;68:1624-1632.
31. 31. Lehner T, et al. T and B cell functions and epitope expression in non-human primates immunized with SIV by the rectal as compared with the systemic route. Proc Natl Acad Sci USA 1993;90:8638-8642.
32. 32. Klavinskis LS, Brookes R, Bergmeier LA, Mitchell E, Tao L, Lehner T. Mucosal or targeted lymph node immunization of macaques with a paniculate SIVp27 protein elicits virus-specific CTL in genito-rectal mucosa and draining lymph nodes. J Immunol 1996;157:2521-2527.
33. 33. Lehner T, et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J Immunol 1994;153:1858-1868.
34. 34. Belyakov IM, et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci USA 1998;95:1709-1714.
35. 35. Brookes R, et al. Generation of diversity in the hierarchy of T-cell epitope responses following different routes of immunization with simian immunodeficiency virus protein. AIDS 1995;9:1017-1024.
36. 36. Mitchell EA, et al. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur J Immunol 1998;28:3066-3074.
37. 37. Pantaleo G, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-357.
38. 38. Embretson JE, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-361.
39. 39. Spira AI, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-225.
40. 40. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984;1:370-372.
41. 41. Tenner-Racz K, et al. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J Invest Dermatol 1987;88:233-237.
42. 42. Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, Haper ME. HTLVIII expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 1986;125:436-442.
43. 43. Zinkernagel RM, Ehl S, Aichelle P, Dehen S, Kindig T, Hengartner H. Antigen localization regulates immune responses in a dose-and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 1997;156:199-209.
44. 44. Miller CJ, et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol 1989;63:4277-4284.
45. 45. Miller CJ, Alexander NJ, Sutjipto S, Hendrickx AG, Jennings M, Marx PA. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol 1990;19:401-409.
46. 46. Cranage MP, et al. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 1992;339:273-274.
47. 47. Pauza CD, Malkovsky M, Salvcata MS. SIV transmission across the mucosal barrier. AIDS Res Hum Retroviruses 1994;10:7-10.
48. 48. Putkonen P, et al. In: Brown F, Lerner RA, eds. Vaccines 96. Cold Spring Harbor NY, Cold Spring Harbor Laboratory Press; 1996. p. 235-241.
49. 49. Fultz PN, et al. Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis 1986;154:896-900.
50. 50. Girard M, Fultz P, Barre Sinoussi F, Muchmore E, Mahoney J, Rimsky L. Further studies on HIV-1 vaccine protection in chimpanzees. In: Girard M, Vallette L, eds. Huitieme Colloque des Cent Gardes. Paris: Pasteur Meriux; 1993. p. 139-143.
51. 51. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992;89:6901-6905.
52. 52. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
53. 53. Wei X, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117.
54. 54. Lohman BL, Miller CJ, McChesney MB. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995;155:5855-5860.
55. 55. Deng H, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-666.
56. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673
57. 57. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
58. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
59. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 1986;8:629-640.
60. + T cells. Science 1995;270:1811-1815.
61. 61. Liu R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
62. 62. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-725.
63. 63. Dean M, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
64. 64. Amamori I, Zhang J, Ferguson SSG, Bieníasz PD, Cullen BR, Caron MG. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997;16:4606-4616.
65. 65. Amara A, et al. HIV coreceptor downregulation as antiviral principle: SDF-1α dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:136-146.
66. + cell antiviral factor. Cell Immunol 1997;153:329-430.
67. 67. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
68. 68. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity 1998;9:1-11.
69. 69. Heeney JL, et al. β-chemokines and neutralising antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA 1998;95:10803-10808.
70. 70. Wang Y, et al. Generation of CD8-SF and β-chemokines, induced by xenogeneic immunization, in the prevention of SIV infection in macaques. Proc Natl Acad Sci USA 1998;95:5223-5228.
71. + T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med (In press).
72. 72. Wang Y, Tao L, Mitchell E, Bergmeier LA, Doyle C, Lehner T. The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis. Vaccine 1999;17:1826-1836.
73. + T-cell phenotype correlates with anti HIV activity and asymptomatic clinical status. Clin Immunopathol 1993;69:106-116.
74. 74. Heeney JL. AIDS; a disease of impaired T helper cell renewal. Immunol Today 1995;16:516-520.
75. 75. Marthas M, et al. Efficacy of live-attenuated and whole inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge. In: Brown F, Channock RM, Ginsberg HS, Lerner RA, eds. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1992. p. 117-122.
76. 76. Lu X, et al. Targeted lymph node immunization with whole inactivated simiar immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vagina challenge with SIVmac251. AIDS 1998;12:1-10.
77. 77. Stokes CR, Finerty S, Gruffydd-Jones TJ, Sturgess CP, Harbour DA. Mucosal infection and vaccination against feline Immunodeficiency virus. J Biotechnol (In press).
78. 78. Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J. Infection of cynomolgus monkey: with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. J Acquir Immune Defic Syndr Hum Retroviro 1992;5:639-646.
79. 79. Lu Y, et al. Vaginal transmission of chimeric simian/human immunodeficiency virus in rhesus macaques. J Virol 1996;70:3045-3050.
80. 80. Cranage MP, et al. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 1997;229:143-154.